Ohio 136th General Assembly Status: Introduced 1 D cosponsors

HB 915 — Require health plans, Medicaid to cover epinephrine and glucagon

Last action — Referred to committee

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House. Introduced May 19, 2026. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

The bill requires health plans and Medicaid to cover epinephrine and glucagon for individuals 18 and younger.

This legislation mandates that health benefit plans and Medicaid programs must provide coverage for epinephrine and glucagon for children aged 18 and younger, while also capping out-of-pocket costs for these medications at $60 per package or dose. It seeks to ensure that necessary medications are accessible without overly burdensome costs.

What this means for you
  • Families: Families with children who need epinephrine or glucagon will benefit from reduced costs for these necessary medications.

Summary

To amend sections 5162.20 and 5167.12 and to enact sections 3902.65 and 5164.094 of the Revised Code to require health benefit plans and the Medicaid Program to cover epinephrine and glucagon for individuals eighteen years of age and younger and to cap cost sharing for epinephrine and glucagon in any form.

Bill Text

Action History

  1. As Introduced

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 133 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (133)

133 members have not signed on to this bill.

Show all 133 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 915 do?
To amend sections 5162.20 and 5167.12 and to enact sections 3902.65 and 5164.094 of the Revised Code to require health benefit plans and the Medicaid Program to cover epinephrine and glucagon for individuals eighteen years of age and younger and to cap cost sharing for epinephrine and glucagon in any form.
Who sponsors HB 915?
HB 915 is sponsored by Phillip M. Robinson, Jr. (Democratic).
What is the current status of HB 915?
This bill has been introduced in the House. Introduced May 19, 2026. It must pass committee before a floor vote.
Where can I track HB 915?
Track HB 915 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 915

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 915

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →